United States · FDA National Drug Code directory
Omidria
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62225-600_4ef3b158-3042-6a1f-e063-6394a90a807f
- Product NDC
- 62225-600
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- phenylephrine and ketorolac
- Labeler
- Omeros Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20140613
- Source listing expiry
- 20271231
Source-listed ingredients
- PHENYLEPHRINE — 10.16 mg/mL
- KETOROLAC — 2.88 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
Package details are not available in this snapshot.
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →